(E25.0) Congenital adrenogenital disorders associated with enzyme deficiency

More details coming soon

Icon
132 170 in individuals diagnosis congenital adrenogenital disorders associated with enzyme deficiency confirmed
Icon
692 deaths with diagnosis congenital adrenogenital disorders associated with enzyme deficiency
Icon
1% mortality rate associated with the disease congenital adrenogenital disorders associated with enzyme deficiency

Diagnosis congenital adrenogenital disorders associated with enzyme deficiency is diagnosed Women are 30.88% more likely than Men

45 681

Men receive the diagnosis congenital adrenogenital disorders associated with enzyme deficiency

692 (1.5 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
86 489

Women receive the diagnosis congenital adrenogenital disorders associated with enzyme deficiency

0 (less than 0.1%)

Died from this diagnosis.

Risk Group for the Disease congenital adrenogenital disorders associated with enzyme deficiency - Men aged 0 and Women aged 15-19

Icon
In Men diagnosis is most often set at age 0-54, 60-69
Icon
Less common in men the disease occurs at Age 55-59, 70-95+Less common in women the disease occurs at Age 75-84, 95+
Icon
In Women diagnosis is most often set at age 0-74, 85-94

Disease Features congenital adrenogenital disorders associated with enzyme deficiency

Icon
Absence or low individual and public risk
Icon

Congenital adrenogenital disorders associated with enzyme deficiency - what does this mean

Congenital adrenogenital disorders associated with enzyme deficiency are caused by mutations in genes that code for enzymes involved in the synthesis of hormones, such as cortisol or aldosterone, from cholesterol. these mutations can lead to a deficiency in the production of these hormones, resulting in a variety of clinical symptoms depending on the specific enzyme affected.

What happens during the disease - congenital adrenogenital disorders associated with enzyme deficiency

Congenital adrenogenital disorders associated with enzyme deficiency is caused by a defect in the enzyme 21-hydroxylase, which is responsible for the conversion of progesterone to cortisol and aldosterone. this leads to a decrease in the production of these hormones, resulting in a variety of symptoms, such as ambiguous genitalia, precocious puberty, hypertension, hypoglycemia, and electrolyte imbalance.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Complete physical examination
  • Blood tests to measure hormone levels
  • Urine tests to measure hormone levels
  • Genetic testing
  • Imaging tests such as ultrasound and MRI
  • Enzyme activity tests
  • Other specialized tests, such as ACTH stimulation test

Treatment and Medical Assistance

Main goal of the treatment: To reduce the symptoms of Congenital adrenogenital disorders associated with enzyme deficiency.
  • Administering hormone replacement therapy
  • Administering oral corticosteroids
  • Monitoring blood pressure and electrolytes
  • Monitoring liver function tests
  • Monitoring growth and development
  • Providing dietary advice
  • Providing psychological support
  • Encouraging physical activity
  • Providing education about the condition
Icon
14 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Congenital adrenogenital disorders associated with enzyme deficiency - Prevention

Prevention of congenital adrenogenital disorders associated with enzyme deficiency is primarily done through genetic counseling and testing prior to pregnancy. couples who are known to be at risk for these disorders should be informed about the risks and options for testing and prenatal diagnosis.